Two Dead Due to H3N2 Flu Virus in India, Confirms Health Ministry

While three seasonal flu viruses have been identified in the country, none of the outbreaks are novel to the country. These viruses have caused morbidity and mortality in previous years also. The cases are expected to decline by March-end.

New Delhi: The Union health ministry on Friday, March 10, confirmed two deaths due to the H3N2 subtype of seasonal influenza – one each in Karnataka and Haryana. Media reports from Karnataka suggest that the one who died was 82-year-old and had comorbidities. The person who died in Haryana was a 52-year-old and was suffering from liver cancer.

So far, 3,038 cases of this type have been reported in India, data from the Integrated Disease Surveillance Project suggests. This includes 1,245 cases in January, 1,307 in February and 486 in March. However, it is worth noting that H3N2 has been reported in previous years also and this is not a novel outbreak. The disease is largely self-limiting, i.e., a patient will recover with or without taking any disease-specific medicine with treatment prescribed merely for symptoms. But those who are immunocompromised (the immune system’s defences are low) or are elderly and/or have comorbidities may experience complications.

The health ministry’s statement said other than H3N2, another subtype of influenza – H1N1 – has also been in circulation in India. As many as 955 H1N1 cases were reported till February. A majority of the H1N1 cases were reported from Tamil Nadu (545), Maharashtra (170), Gujarat (74), Kerala (42) and Punjab (28). Both these subtypes have been identified in India for many years now.

H3N2 has been the dominant subtype followed by H1N1. Both these subtypes belong to Influenza ‘A’ type. Cases of influenza ‘B’ type virus (of the Victoria lineage) have also been confirmed in the past nine weeks of this year in the country. These two types of influenza viruses have been known to cause outbreaks, unlike Influenza ‘C’ and Influenza ‘D’.

The health ministry’s statement said the rise in influenza cases in India is not an isolated phenomenon and the “cases are seen to increase during certain months globally.” Talking about the virus’s seasonality, the ministry said there are two peak seasons: from January to March; and after the monsoon season. “The cases arising from seasonal influenza are expected to decline from March-end,” it said.

The Indian Council of Medical Research (ICMR) had said earlier that H3N2 appears to cause more hospitalisations than other influenza subtypes. Of all hospitalised cases, 6% had clinical signs of pneumonia and 6% had seizures. Out of all those hospitalised, 7% went on to develop severe disease, requiring ICU care and 10% needed supplemental oxygen.

Since antibiotics do not figure in the treatment protocol for any virus, they are not used to treat flu caused by influenza. If the patient develops a secondary bacterial infection, doctors prescribe antibiotics. The ICMR has advised people to wear masks in crowded places because the route of transmission is respiratory. For body aches and fever, paracetamol is prescribed.

Why India’s Slowly Blooming Mushroom Sector Needs Thoughtful Policy Intervention

Since mushrooms are neither plants nor animals and emerge not from seeds but from spawns or spores, they are outside the ambit of the Seed Act and Rules and also the PPVFR Act.

As winter approaches, India’s farmers once again are exploring the mushroom option as a means of boosting their incomes

The lockdown has sparked new opportunity and fungi farms are mushrooming across the country. Many predict that mushrooms are the next high value agriculture crop which can transform incomes of small and marginal farmers.

How big is the mushroom wave?

Well, as per government data India in 2013-14 produced 17,100 metric tonnes of mushrooms, and by 2018 this increased to 4,87,000 MT (about 29 fold increase in four years). Yet India only accounts for about 2% of the world’s mushroom production, as the lion’s share is with China which accounts for over 75% of global production.

States like Uttar Pradesh have already emerged as the top producers in India, but as consumption is still low – 30 gram per person when compared to US or Europe (2 kg-3 kg per person) – there is a huge opportunity, both domestically and for exports, yet to be harnessed.

Mushroom Area (Area in ‘000 Ha) Production (Production in ‘000 MT)
2013-14 NA** 17.10
2014-15 NA** 51
2015-16 170 436
2016-17 182 441
2017-18 198 487
*Data from National Horticulture Board **NA – Not available

The mushroom ecosystem – spawning units, composter, marketing and allied services are slowly emerging too. Sonepat, Gorakhpur, etc are emerging as major centres for domestic production.  Yet surprisingly there are no laws that regulate the mushroom sector. 

Also read: The Women Mushroom Farmers of Anantpur

Technically, mushrooms are neither plants nor animals and they don’t emerge from seed but from spawns or spores. This uniqueness keeps these non-photosynthetic life-forms out of the purview of the Seed Act and Rules and also the PPVFR Act. In simple words, the mushrooms sector is unregulated. 

Adding to regulatory troubles, the Patent Act 1970 is also not clear on the patentability of fungi – even as other countries like the United States recognises patents on new varieties of fungi or mushrooms. One feels as fungi are autonomous living beings and they are excluded from patentability in India. Article 3 (c) & (j) of the Act may supports this view.

Nevertheless, clarity needs to be given by the courts as this will be big issue as mushroom cultivation grows in India. 

Meanwhile, where does a mushroom farmers go, if they has been given a bad spawn or spores (spawns and spores are mycelium that colonise a substratum to produce mushrooms)? Which standard should industry, entrepreneurs and farmers abide by in production or purchasing spawns from the market?

Many farmers already complain of being duped on e-retail websites, etc, but due to lack of redressal mechanisms suffer in silence. There are also reports of spawn units cheating farmers by supplying inferior spawns and spores cultures due to lack of a mushroom eco-system across the country.

A merchant selling Oyster Mushrooms grown indoors. Photo: Wikimedia Commons, CC BY-SA 4.0

Spawns or spores need to be kept at a regulated temperature and for a limited time only, otherwise, they will lose their efficiency to produce mushrooms. The Seed Act does not have jurisdiction here, and no separate act exists that sets these guidelines for mushrooms industry or growers. The modus operandi followed by spawn and compost traders in India is not regularised either.

Further, no laws protect the intellectual property rights or mushroom growers’ varieties. What happens when patented mushrooms lines and products start entering the Indian markets? Will those patents be applicable on Indian soil and do our mushroom farmers have to send royalties abroad? This is a grey zone and deters foreign direct investment and new technologies from entering India. 

Mushroom biodiversity is another quagmire for India has hardly tapped into her native biodiversity of mushrooms for medicinal or edible purposes. For instance, the love affair with button mushroom is turning out to be a disaster for other species like native oysters, milky, paddy straw mushrooms, etc.

Also read: Forced to Forage for Food by the Lockdown, and Poisoned by Mushrooms

Plus how effective our national biodiversity laws have been in regulating foreign spores, etc entering India, is another cause of concern. The scale is such that one big flask of a pure culture of spawns is enough to seed the entire country’s button mushroom production hence we have to be cautious of genetic bottlenecking. India needs to nourish herself by harnessing the full genetic biodiversity, and bring all nutrients and vitamins of the mushroom family to our thalis.   

To correct our course, Indian policymakers need to create a separate committee for the creation of policies and laws in consultations with mycologists, farmers and industry. This body can produce training SOP, purity standards, operating procedures and redressal systems for farmers and industry much like the Seed Act. A separate sub-department is needed from the horticulture department. In the interim period, a notification can empower officials within the horticulture department to aid farmers and industry for grievance redressal. The patent question is gnarly and would need help more legal and biodiversity experts. Our regulators have been silent still now on these critical questions. 

By embracing and regulating mushrooms the government may have a new ally to combat malnutrition and falling farm incomes. Fungi may also help converts millions of tonnes of paddy stubble into edible mushrooms instead of noxious smog.  Mushrooms are a gold mine; DARPA already funded and patented along with renowned mycologist Paul Stamets various medicinal uses of mushrooms, including treatment for H1n1 virus. India needs tap into the medicinal R&D with her farmers too. But before the mushroom sector gets any bigger, the government needs to create regulations so farmers and industry can harness the full potential of fungi.  

Indra Shekhar Singh is Director of Policy and Outreach at the National Seed Association of India.

Next Flu Pandemic ‘a Matter of When, Not If,’ Says WHO

“We must be vigilant and prepared – the cost of a major influenza outbreak will far outweigh the price of prevention,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus.


The World Health Organization (WHO) on Monday outlined a global plan for fighting influenza and trying to prevent or slow any worldwide outbreak of the viral disease, warning that the danger of a pandemic was “ever-present”.

“The question is not if we will have another pandemic, but when,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus in a statement on the WHO website. “We must be vigilant and prepared – the cost of a major influenza outbreak will far outweigh the price of prevention.”

Among other things, Dr Tedros warned of the risk that a new influenza virus could transmit from animals to humans to trigger such a pandemic.

“With the partnerships and country-specific work we have been doing over the years, the world is better prepared than ever before for the next big outbreak, but we are still not prepared enough,” he said. “This strategy aims to get us to that point.”

The WHO said there were an estimated 1 billion cases of flu each year, resulting in 290,000 to 650,000 respiratory deaths.

Strengthening national capacities

An image of the H1N1 influenza virus. Credit: CDC

An image of the H1N1 influenza virus. Credit: CDC

The UN recommends annual vaccinations to combat the disease, particularly for people working in health care and high-risk groups such as the old, the very young and those suffering from underlying illnesses.

The plan aims to build stronger national capacities to fight the disease, calling on countries to each have a special influenza program. It also wants to develop better tools for preventing, detecting, controlling and treating the disease and make these tools accessible for all countries. Anti-flu measures include vaccines and antiviral drugs.

The world’s last flu pandemic was in 2009 and 2010 and was caused by the H1N1 virus. At least one in five people across the world is thought to have been infected, with a mortality rate of around 0.02%, amounting to 18,500 deaths in 214 countries.

This article was originally published on DW. Read the original article here.

Vector-Borne Diseases Have Claimed 1,010 Lives So Far: Government

A total of 632 people died due to influenza (H1N1), while Aedes Aegypti (AES) and Japanese Encephalitis (JE) claimed 279 and 60 lives respectively.

The Aedes aegypti, mosquito, spreads dengue and chikungunya. Credit: Wikimedia Commons

The Aedes aegypti, mosquito, spreads dengue and chikungunya. Credit: Wikimedia Commons

New Delhi: Vector-borne diseases have claimed 1,010 lives so far this year, including 632 deaths due to H1N1, the government informed the Lok Sabha.

Stating that there is a broad strategy to control vector- borne diseases, health minister J.P. Nadda said the government would strengthen surveillance and diagnostic systems.

A total of 632 people died due to influenza (H1N1), while Aedes Aegypti (AES) and Japanese Encephalitis (JE) claimed 279 and 60 lives, respectively, this year till July 16, according to data provided by the minister as part of a written reply.

As per data available for this year, while 22 people died on account of dengue till July 9, Malaria claimed the lives of 17 people in 2017 up to May and altogether 1,010 people have died this year due to these vector-borne diseases.

Listing out the steps taken to combat vector-borne diseases, the minister said there is also coordination with the Integrated Disease Surveillance Programme (IDSP) to detect early warning signals such as any upsurge in fever cases or any reports of malaria outbreaks.

Asked whether the government plans to start a national programme in public private partnership mode for prevention of vector-borne diseases, Nadda said there is no such proposal as on date, but he however mentioned about the memorandum of understanding between Madhya Pradesh, ICMR (Indian Council of Medical Research) and Sun Pharma for the malaria elimination initiatives, among other such programmes.

The minister also said the Centre ensures deputation of teams with specialist doctors to guide and supervise the efforts of the state governments to help in reduction of morbidity and mortality due to the outbreak of vector-borne diseases.

To another question, Nadda said there is no proposal at the ministry level to get ISO certification for primary and community health centres.

“National Quality Assurance Programme (NQAP) has been rolled out, under which quality standards for different health facilities, including primary health centres and community health centres have been defined and these health facilities are assessed against them and certified,” he said.

As far as quality assurance of these centres is concerned, it is for the states to see, Nadda said, adding that the central government provides technical and financial support.

There are 25,354 functional primary health centres and 5,510 community health centres in the country, official data showed.

18 Fresh Swine Flu Cases Reported in Telangana

Eighty-five cases were tested for swine flu on February 1, 18 of which came back positive.

File photo of people waiting in a queue for a H1N1 flu screening. Credit: Reuters

File photo of people waiting in a queue for a H1N1 flu screening. Credit: Reuters

Hyderabad: Eighteen fresh positive cases of swine flu have been reported in Telangana, where 13 people have succumbed to the H1N1 virus and other complications since August 1 last year.

Eighty-five cases were tested for swine flu on February 1, 18 of which came back positive, a bulletin on swine flu issued by the state government said on February 2.

It said 250 cases among 3,696 samples tested since August 1 last year were found positive for the virus.

No death was reported, it said.

The bulletin also said sufficient stock of medicines and testing kits were available in the state.

The bulletin advised citizens to take precautions upon first symptoms of swine flu like high fever, sneezing, cough and body pain.